Valerio Therapeutics Société anonyme (EPA:ALVIO)
France · Delayed Price · Currency is EUR 0.0540
+0.0004 (0.74%)
Jul 18, 2025, 12:28 PM CET
EPA:ALVIO Revenue
In the year 2024, Valerio Therapeutics Société anonyme had annual revenue of 1.79M EUR, down -0.39%. Valerio Therapeutics Société anonyme had revenue of 1.70M in the half year ending December 31, 2024, with 18.09% growth.
Revenue
1.79M
Revenue Growth
-0.39%
P/S Ratio
4.63
Revenue / Employee
47.18K
Employees
19
Market Cap
8.31M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.79M | -7.00K | -0.39% |
| Dec 31, 2023 | 1.80M | 357.00K | 24.74% |
| Dec 31, 2022 | 1.44M | -2.62M | -64.48% |
| Dec 31, 2021 | 4.06M | 2.29M | 128.72% |
| Dec 31, 2020 | 1.78M | -2.51M | -58.59% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| EssilorLuxottica Société anonyme | 26.51B |
| Sanofi | 45.17B |
| Sartorius Stedim Biotech | 2.86B |
| bioMérieux | 3.98B |
| Eurofins Scientific SE | 6.95B |
| Ipsen | 3.57B |
| Virbac | 1.40B |
| Clariane SE | 5.28B |